SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor ($TAO) is trending as the community debates its long-term potential as a 'Bitcoin of AI' amidst volatility triggered by a major subnet operator leaving the network. While some investors fear centralization and governance issues, others are actively accumulating, viewing the recent price swings as a 'buy the fear' opportunity to gain exposure to the growing decentralized AI infrastructure.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate as the token's massive appreciation sparks accusations of an orchestrated pump-and-dump scheme. While proponents highlight upcoming global event partnerships and a unique Web3-music narrative, critics and on-chain analysts are pointing to high supply concentration and warning of potential market manipulation.

Highstreet

Highstreet ($HIGH) is drawing significant community attention as traders debate whether its low circulating supply and recent price volatility signal an imminent short squeeze or a potential bear trap. Many participants are actively monitoring whale accumulation patterns and technical indicators, hoping for a rebound toward previous higher valuations.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is seeing increased investor focus due to a series of upcoming Phase 3 clinical readouts for its lead psychedelic pipeline and ongoing discussions regarding its strategic repositioning. While community sentiment remains divided over the firm's history of leadership changes and reverse splits, bulls are optimistic about the potential for breakthrough data to serve as a significant value catalyst.

MNDE is the governance token for Marinade. Marinade helps you to stake Solana without locking in liquidity by turning SOL into mSOL - tokenized version of staked SOL. This way you can both secure the network by staking SOL, and use your mSOL as the ultimate unit in Solana DeFi ecosystem. To provide liquidity, deposit in lending protocols and even buy NFTs.

Marinade

Marinade is seeing increased chatter as investors speculate on a breakout, with many in the community highlighting its significant total value locked relative to its market cap. Traders are actively tracking bullish technical patterns and potential institutional integration, viewing it as an undervalued play within the Solana ecosystem.

Daddy Darth Sidious

The community is actively debating a potential sector rotation among meme tokens, with traders closely monitoring price movements for opportunities to pivot between competing assets. Sentiment remains polarized as participants weigh the speculative nature of these tickers against aggressive attempts to drive volume and market interest.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant volatility following a corporate rebranding and Nasdaq listing, with the community sharply divided between those optimistic about its upcoming Phase 2 generalized anxiety disorder data and Phase 3 major depressive disorder milestones and skeptics pointing to a history of dilution and management concerns. Investors are closely monitoring the company's capital runway and leadership changes while debating whether the stock's current valuation represents a distressed entry point for a potential acquisition or a continued downward trend.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy is gaining traction as a community-driven project focused on restoring classic internet culture and leveraging the original Ragemaker tool. The community is actively promoting its ownership of iconic meme domains and emphasizing a "bag-working" mentality as they aim to establish the token as a top player in the meme sector.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as market sentiment shifts toward psychedelic biotech following positive momentum in trial milestones and broader policy discussions regarding expanded access for mental health therapies. The community remains focused on upcoming phase 3 trial readouts, the company's cash runway, and the potential for strategic sector partnerships as investors weigh regulatory progress against the binary risk inherent in clinical-stage biotech.

Rewarding holding and rejecting the culture of fast flips. Longterm sustainability by using a multi-phase dynamic rewards system. Meme that inspires creativity and innovation. Fun community involvement, including games, memes, and also serious holder mindset. We have automated rewards to holders, buyback and burns and are giving back to ocean cleanup initiatives. All pump fun creator rewards are used for the buyback and burn of the token, rewarding holders, and donating to nonprofits that clean our oceans.

MAKE HOLDING GREAT AGAIN

MHGA is gaining momentum on the Solana blockchain, driven by its recent listing on major platforms and a unique rewards structure that distributes dividends to long-term holders. The community is actively discussing the project's utility, including its charity initiatives and the passive income potential provided by its creator fee mechanism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oak Harvest Investment Services Raises Stake in Teva Pharmaceutical Industries Ltd. $TEVA

Oak Harvest Investment Services boosted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 154.8% in the fourth quarter, according to the company in its most...

J&J Targets Double-Digit Growth by 2030 Despite Stelara Drag

J&J targets double-digit growth by 2030 despite Stelara hit, banking on Innovative Medicine strength, MedTech gains and new launches.

Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Greenwood Capital Associates LLC

Greenwood Capital Associates LLC lowered its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent...

Sumitomo Mitsui Trust Group Inc. Sells 469,305 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

Sumitomo Mitsui Trust Group Inc. reduced its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 19.1% in the fourth quarter, according to its most recent disclosure with the...

J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook

JNJ tops Q1 earnings and sales estimates, lifts 2026 outlook as strong oncology and MedTech growth offset steep Stelara decline.

AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook

Amneal Pharmaceuticals heads into 2026 with diversified growth drivers, rising margins and a faster launch cadence supporting steady revenue expansion.

Is AMRX Stock Undervalued? Sales Multiple, Target, Upside

Amneal Pharmaceuticals trades below peers on sales multiple despite strong gains, with a $14 target hinging on execution, mix shift, and margin strength.

Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides.

Teva Pharmaceutical Industries (NYSE:TEVA) Given New $42.00 Price Target at Bank of America

Bank of America raised their target price on shares of Teva Pharmaceutical Industries from $38.00 to $42.00 and gave the stock a "buy" rating in a research note on Thursday...

Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?

JNJ approaches Q1 results with strong drug growth and MedTech momentum. However, rising biosimilar competition and pricing pressures cloud the outlook.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

TEVA
Teva- Pharmaceutical Industries Ltd. - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TEVA News

TEVATeva- Pharmaceutical Industries Ltd. - ADR